Mesothelioma | Mesothelioma news | Breaking lung cancer news | Mesothelioma | Mesothelioma

Sunesis Pharma Says It Will Present Data On Clinical-Stage Product ...

...SNS-032 is in a Phase I/II clinical studies to examine the safety and preliminary anti-tumor activity among patients with Sunesis is currently conducting preclinical studies of its Aurora kinase inhibitor drug candidate, SNS-314.

Copyright(c) 2006 RealTimeTraders.com, Inc.

All Rights Reserved <<< Return More BREAKING NEWS > More News Top Stories What Customers Are Saying All analyst commentary provided on TradingMarkets.com is provided for educational purposes only.

The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here.

This information is NOT a recommendation or solicitation to buy or sell any securities.

Your use of this and all information contained on TradingMarkets.com is governed...

Read more...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news

Lung Cancer   Best Cancer Care   Breast Cancer